Literature DB >> 17452543

Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study.

Mercedes R Carnethon1, Mary L Biggs, Joshua I Barzilay, Nicholas L Smith, Viola Vaccarino, Alain G Bertoni, Alice Arnold, David Siscovick.   

Abstract

BACKGROUND: Prospective studies indicate that a single self-report of high depressive symptoms is associated with an increased risk of developing type 2 diabetes mellitus.
METHODS: We tested whether a single report of high depressive symptoms, an increase in depressive symptoms, or persistently high depressive symptoms over time were associated with the development of diabetes in adults 65 years and older. Participants from the Cardiovascular Health Study completed the 10-item Center for Epidemiological Studies-Depression Scale (CES-D) annually from 1989 to 1999. A single report of high depressive symptoms (CES-D score, >/=8), an increase in symptoms during follow-up (>/=5 from baseline), and persistently high symptoms (2 consecutive scores >/=8) were each studied in relation to incident diabetes, defined by initiation of diabetes control medications among participants who were free from diabetes at baseline (n = 4681).
RESULTS: The mean CES-D score at baseline was 4.5 (SD, 4.5). The incidence rate of diabetes was 4.4 per 1000 person-years. Following adjustment for baseline demographic characteristics and measures of physical activity, smoking, alcohol intake, body mass index, and C-reactive protein during follow-up, each measure of depressive symptoms was significantly associated with incident diabetes (high baseline CES-D score: hazard ratio, 1.6 [95% confidence interval, 1.1-2.3]; CES-D score increase: hazard ratio, 1.5 [95% confidence interval, 1.1-2.2]; and persistently high symptoms: hazard ratio, 1.5 [95% confidence interval, 1.1-2.3]).
CONCLUSION: Older adults who reported higher depressive symptoms were more likely to develop diabetes than their counterparts; this association was not fully explained by risk factors for diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452543     DOI: 10.1001/archinte.167.8.802

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  46 in total

1.  Comparison of short scales to measure depressive symptoms in elders with diabetes.

Authors:  Jaclene A Zauszniewski; Gregory C Graham
Journal:  West J Nurs Res       Date:  2008-12-02       Impact factor: 1.967

2.  Trajectories of Nonagenarian Health: Sex, Age, and Period Effects.

Authors:  Michelle C Odden; William Jen Hoe Koh; Alice M Arnold; Andreea M Rawlings; Bruce M Psaty; Anne B Newman
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

3.  Race-related differences in depression onset and recovery in older persons over time: the health, aging, and body composition study.

Authors:  Lisa C Barry; Roland J Thorpe; Brenda W J H Penninx; Kristine Yaffe; Dorothy Wakefield; Hilsa N Ayonayon; Suzanne Satterfield; Anne B Newman; Eleanor M Simonsick
Journal:  Am J Geriatr Psychiatry       Date:  2013-10-11       Impact factor: 4.105

4.  Adverse childhood events and current depressive symptoms among women in Hawaii: 2010 BRFSS, Hawaii.

Authors:  Rosemay A Remigio-Baker; Donald K Hayes; Florentina Reyes-Salvail
Journal:  Matern Child Health J       Date:  2014-12

Review 5.  The interface of physical and mental health.

Authors:  Anne M Doherty; Fiona Gaughran
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-22       Impact factor: 4.328

6.  [Depression in late life].

Authors:  W Hewer; D Kopf
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

7.  The comorbidity of diabetes mellitus and depression.

Authors:  Wayne J Katon
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

8.  Examining a bidirectional association between depressive symptoms and diabetes.

Authors:  Sherita Hill Golden; Mariana Lazo; Mercedes Carnethon; Alain G Bertoni; Pamela J Schreiner; Ana V Diez Roux; Hochang Benjamin Lee; Constantine Lyketsos
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

9.  Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Authors:  Robert H Howland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

10.  Depressive symptoms and risk of type 2 diabetes in a national sample of middle-aged and older adults: the English longitudinal study of aging.

Authors:  Panayotes Demakakos; Mary B Pierce; Rebecca Hardy
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.